In vitro fertilization, ovulation induction and the risk of cancer

CME Journal of Gynecologic Oncology

Volumn 9, Issue 3 PART 4, 2004, Pages 256-263

  Burger, Curt W ^a   Klip, Helen ^b   Van Leeuwen, Flora E ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Endometrial cancer; Fertility drugs; Infertility; Melanoma; Ovarian cancer; Thyroid cancer

Indexed keywords

CLOMIFENE CITRATE;

ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HORMONAL CARCINOGENESIS; HUMAN; INFERTILITY THERAPY; MELANOMA; NULLIPARA; OVARY CANCER; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PARITY; THYROID CANCER;

EID: 35848931914     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Koudstaal J, van Dop PA, Hogerzeil HV, Kremer JA, Naaktgeboren N, Van Os HC et al. Pregnancy course and outcome in 2956 pregnancies after in-vitro fertilization in Netherlands]. Ned Tijdschr Geneeskd 1999;143:2375-2380.
2. Wysowski DK. Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril 1993; 60:1096-8
3. de Jong- van den Berg LTW, Cornel MC, van den Berg PB, et al. Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population. Int J Risk Safety Med 1992;3: 99-112.
4. Klip H, Burger CW, Kenemans P, Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes and Control 2000;11:319-344
5. Venn A, Cancer risk associated with the diagnosis of infertility. Best Practice & Research Clinical Obstet & Gynaecol 2003;17/2:343-67
6. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G et al. Cancer incidence in a cohort of infertile women. Am.J Epidemiol 1987;125:780-90.
7. Brinton LA, Melton LJ, Malkasian Jr GD, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-22.
8. Rossing, MA, Daling, JR and Weiss, NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6
9. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995;346:995-1000.
10. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-42
11. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A., Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril. 1999;71: 853-9.
12. Venn A, Watson L, Bruinsma F, Giles, G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation Lancet 1999;354:1586-90
13. Whittemore, AS, Wu, ML, Paffenbarger, Jr, RS, Sarles, DL, Kampert, JB, Grosser, S et al. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989;49:4047-52
14. Whittemore, AS, Harris, R, Itnyre, J. Characteristics relating to ovarian cancer risk: collabora tive analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-1203
15. Whittemore, AS, Harris, R, Itnyre J, Halpern J Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1175-83
16. Schildkraut, JM, Schwingl, PJ, Bastos, E, Evanoff, A, Hughes, C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554-9
17. Ness RB, Cramer DW, Goodman MT et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case control studies. Am J Epidemiology 2002;155:217-224
18. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176: 572-579.
19. Rodriguez, C, Tatham, LM, Calle, EE, Thun, MJ, Jacobs, EJ, Heath, Jr CW. Infertility and risk of fatal ovarian cancer in a prospective cohort of US women. Cancer Causes Control 1998;9:645-51
20. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai Cancer Res 1989;49: 3670-3674
21. Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994;9:1673-1675.
22. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-18
23. Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod 1997;12: 2159-2161
24. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005-1012
25. Harris R, Whittemore, AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1204-11
26. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemicology. Epidemiol Rev 1993;15: 7-16
27. Dor J, Lener-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertility women who underwent in vitro fertilization. Fert Steril 2002;77:324-327
28. Rossing MA, Daling JR, Weiss NS. Risk of ovarian cancer after treatment for infertility. N Engl J Med 1995;332:1302-8
29. Sutherland RL, Watts CK, Hall RE, Ruenitz PC. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J Steroid Biochem 1987;27: 891-897.
30. Brinton LA, Berman ML, Mortel R et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992;167: 1317-1325
31. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57: 205-212
32. Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 1991;77: 124-128.
33. Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens. Cancer Epidemiol Biomarkers Prev 1994;3: 661-668.
34. Holman CD, Armstrong BK, Heenan PJ Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984;50: 673-680.
35. Bernstein L, Ross RK, Henderson BE. Relationship of hormone use to cancer risk. J Natl Cancer Inst Monogr 1992;137-147.